Survival of transfused α2-plasmin inhibitor in a patient with its congenital deficiency
- 1 May 1981
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 22 (3) , 281-286
- https://doi.org/10.1016/0049-3848(81)90120-1
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Fibrinolytic states in a patient with congenital deficiency of alpha 2- plasmin inhibitorBlood, 1980
- Congenital Deficiency of α2-Plasmin Inhibitor Associated with Severe Hemorrhagic Tendency *Journal of Clinical Investigation, 1979
- Natural inhibitors of fibrinolysisProgress in Cardiovascular Diseases, 1979
- Turnover of antiplasmin, the fast-acting plasmin inhibitor of plasmaBlood, 1979
- The α2-plasmin inhibitor levels in liver diseasesClinica Chimica Acta; International Journal of Clinical Chemistry, 1978
- The behavior of alpha2-plasmin inhibitor in fibrinolytic states.Journal of Clinical Investigation, 1977
- Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B.Journal of Clinical Investigation, 1977
- The primary inhibitor of plasmin in human plasmaBiochemical Journal, 1976
- Identification and Some Properties of a New Fast‐Reacting Plasmin Inhibitor in Human PlasmaEuropean Journal of Biochemistry, 1976
- Solid state lactoperoxidase: A highly stable enzyme for simple, gentle iodination of proteinsBiochemical and Biophysical Research Communications, 1972